Free Trial
NASDAQ:GRAL

GRAIL (GRAL) Stock Price, News & Analysis

GRAIL logo
$39.99 +0.28 (+0.69%)
As of 11:11 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About GRAIL Stock (NASDAQ:GRAL)

Key Stats

Today's Range
$39.01
$40.29
50-Day Range
$34.35
$51.42
52-Week Range
$12.33
$63.99
Volume
105,645 shs
Average Volume
1.42 million shs
Market Capitalization
$1.44 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$31.50
Consensus Rating
Hold

Company Overview

GRAIL Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
14th Percentile Overall Score

GRAL MarketRank™: 

GRAIL scored higher than 14% of companies evaluated by MarketBeat, and ranked 866th out of 922 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    GRAIL has received a consensus rating of Hold. The company's average rating score is 2.25, and is based on 1 buy rating, 3 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    GRAIL has only been the subject of 1 research reports in the past 90 days.

  • Read more about GRAIL's stock forecast and price target.
  • Earnings Growth

    Earnings for GRAIL are expected to grow in the coming year, from ($15.15) to ($12.95) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of GRAIL is -0.66, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of GRAIL is -0.66, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    GRAIL has a P/B Ratio of 0.54. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about GRAIL's valuation and earnings.
  • Percentage of Shares Shorted

    20.81% of the float of GRAIL has been sold short.
  • Short Interest Ratio / Days to Cover

    GRAIL has a short interest ratio ("days to cover") of 4.3.
  • Change versus previous month

    Short interest in GRAIL has recently increased by 4.03%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    GRAIL does not currently pay a dividend.

  • Dividend Growth

    GRAIL does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    20.81% of the float of GRAIL has been sold short.
  • Short Interest Ratio / Days to Cover

    GRAIL has a short interest ratio ("days to cover") of 4.3.
  • Change versus previous month

    Short interest in GRAIL has recently increased by 4.03%, indicating that investor sentiment is decreasing.
  • News Sentiment

    GRAIL has a news sentiment score of 1.48. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 1.05 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 7 news articles for GRAIL this week, compared to 7 articles on an average week.
  • Search Interest

    Only 5 people have searched for GRAL on MarketBeat in the last 30 days. This is a decrease of -38% compared to the previous 30 days.
  • MarketBeat Follows

    12 people have added GRAIL to their MarketBeat watchlist in the last 30 days. This is an increase of 140% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, GRAIL insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $23,868,412.00 in company stock.

  • Percentage Held by Insiders

    Only 1.85% of the stock of GRAIL is held by insiders.

  • Read more about GRAIL's insider trading history.
Receive GRAL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GRAIL and its competitors with MarketBeat's FREE daily newsletter.

GRAL Stock News Headlines

The End of Elon Musk…?
The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.
See More Headlines

GRAL Stock Analysis - Frequently Asked Questions

GRAIL's stock was trading at $17.85 on January 1st, 2025. Since then, GRAL shares have increased by 124.1% and is now trading at $39.9950.

GRAIL, Inc. (NASDAQ:GRAL) released its quarterly earnings results on Tuesday, May, 13th. The company reported ($3.10) earnings per share (EPS) for the quarter, beating the consensus estimate of ($4.03) by $0.93. The company earned $31.84 million during the quarter, compared to analysts' expectations of $35.80 million. GRAIL had a negative trailing twelve-month return on equity of 17.99% and a negative net margin of 1,464.53%.
Read the conference call transcript
.

GRAIL's top institutional investors include Aberdeen Group plc (0.58%), Douglas Lane & Associates LLC (0.47%), Slow Capital Inc. (0.40%) and Dakota Wealth Management (0.14%). Insiders that own company stock include Chun R Ding, Robert P Ragusa, Joshua J Ofman and Aaron Freidin.
View institutional ownership trends
.

Shares of GRAL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that GRAIL investors own include NVIDIA (NVDA), Tesla (TSLA), Advanced Micro Devices (AMD), Meta Platforms (META), Netflix (NFLX), JPMorgan Chase & Co. (JPM) and Visa (V).

Company Calendar

Last Earnings
5/13/2025
Today
7/24/2025
Next Earnings (Estimated)
8/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Healthcare
Current Symbol
NASDAQ:GRAL
Previous Symbol
NASDAQ:GRAL
CIK
1699031
Web
N/A
Fax
N/A
Employees
1,360
Year Founded
N/A

Price Target and Rating

High Price Target
$43.00
Low Price Target
$20.00
Potential Upside/Downside
-20.7%
Consensus Rating
Hold
Rating Score (0-4)
2.25
Research Coverage
4 Analysts

Profitability

EPS (Trailing Twelve Months)
($60.99)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$2.03 billion
Net Margins
-1,464.53%
Pretax Margin
-1,594.58%
Return on Equity
-17.99%
Return on Assets
-15.02%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
9.70
Quick Ratio
9.71

Sales & Book Value

Annual Sales
$125.60 million
Price / Sales
11.38
Cash Flow
$27.97 per share
Price / Cash Flow
1.42
Book Value
$74.50 per share
Price / Book
0.53

Miscellaneous

Outstanding Shares
35,970,000
Free Float
35,307,000
Market Cap
$1.43 billion
Optionable
Optionable
Beta
N/A
7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

This page (NASDAQ:GRAL) was last updated on 7/25/2025 by MarketBeat.com Staff
From Our Partners